Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study of Montelukast as Prophylaxis for Upper Respiratory Tract Infections in Children

NCT00551382 is registered in ClinicalTrials.gov with Assaf-Harofeh Medical Center as lead sponsor.

NCT NCT00551382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00551382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study of Montelukast as Prophylaxis for Upper Respiratory Tract Infections in Children
Lead sponsor
Assaf-Harofeh Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
November 30, 2007
Completion date
June 30, 2010
Enrollment
500 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

upper respiratory tract infection